Growth Company Investor Show

RNS Number : 1115W

Advanced Medical Solutions Grp PLC

06 June 2008

 



For immediate release

6 June 2008

RNS REACH

Advanced Medical Solutions Group plc

('AMS' or 'the Company')

To exhibit at Growth Company Investor Show on 11 June 2008

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, today announces that it will be exhibiting at the forthcoming Growth Company Investor Show to be held at the Barbican Exhibition Halls, London, on Wednesday 11 June 2008.

AMS will be represented by Don Evans, Chief Executive, and Chris Meredith, Commercial Director, on Stand No 68. 

Attendees at the show will be welcome to visit AMS's stand and talk to the Company's senior management about recent newsflow and Company strategy along with having the opportunity to view some of the Company's products.

Now in its fourth year, the Growth Company Investor Show brings together leading small and mid-cap quoted companies giving existing and potential new investors the opportunity to meet and network with the companies' management teams. Further details are available at

www.growthcompanyinvestorshow.co.uk/show/ .

-ENDS-

For further information, please contact:

Advanced Medical Solutions Group plc	Tel : [phone]
Don Evans, Chief Executive Mary Tavener, Finance Director www.admedsol.com

Buchanan Communications	Tel: [phone]
Mark Court, Mary-Jane Johnson

Notes to Editors:

Advanced Medical Solutions is a leading company in the development, manufacture and sale of products into the $15 billion global woundcare market.

Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative products for advanced woundcare and wound closure.

In-house natural and synthetic polymer technology is used to provide advanced wound dressings based on the moist healing principle. AMS' resources ensure a unique position as a vertically integrated 'one stop shop' to provide all categories of moist wound healing products. The Company has the capability to move a product from design and development through to production and delivery ready for distribution into customer markets.

AMS' technology in cyanoacrylate based tissue adhesives is used either for the closure of small cuts and trauma wounds through to large surgical incisions, or for protecting or sealing skin to prevent breakdown or infection. 

AMS' products currently serve the majority of the key global markets sold either direct or through strategic partners or distributors.

 

END

 

 

NRAUUURUQUPRGQA